Demographics (3)
- age_onset - Disease onset age (phv00383584.v1.p1)
- sex - Gender of participant (phv00383585.v1.p1)
- SEX - Sex (phv00383578.v1.p1)
Disease Events (1)
- AFFECTION_STATUS - Case (Statin-induced myopathy) - control status of the subject (phv00383573.v1.p1)
Race and Ethnicity (1)
- race - Race of participant (phv00383586.v1.p1)
Other (21)
- ANALYTE_TYPE - Analyte Type (phv00383595.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00383594.v1.p1)
- CK - Creatine kinase levels (phv00383590.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00383572.v1.p1)
- FAMILY_ID - Family ID (phv00383574.v1.p1)
- FATHER - Father's Subject ID (phv00383577.v1.p1)
- IS_TUMOR - Tumor status (phv00383596.v1.p1)
- MOTHER - Mother's Subject ID (phv00383576.v1.p1)
- Pain - Muscle pain (phv00383591.v1.p1)
- SAMPLE_ID - De-identified Sample ID (phv00383593.v1.p1)
- SAMPLE_ID - Sample ID (phv00383581.v1.p1)
- SAMPLE_USE - Sample Use (phv00383582.v1.p1)
- Statin - Type of statin (phv00383587.v1.p1)
- Statin dose - Daily statin dose (mg) (phv00383588.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00383583.v1.p1)
- SUBJECT_ID - Unique Subject ID (phv00383575.v1.p1)
- SUBJECT_ID - Subject ID (phv00383571.v1.p1)
- SUBJECT_ID - Subject ID (phv00383580.v1.p1)
- Sx post-therapy (mos) - Time in months that symptoms continued following cessation of therapy (phv00383589.v1.p1)
- TWIN_ID - Twin ID for monozygotic twins or multiples. A TWIN_ID is not provided for dizygotic twins or multiples. (phv00383579.v1.p1)
- Weakness - Weakness (phv00383592.v1.p1)